308 related articles for article (PubMed ID: 15615499)
21. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
[TBL] [Abstract][Full Text] [Related]
22. IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivo.
Rubin J; Fan X; Rahnert J; Sen B; Hsieh CL; Murphy TC; Nanes MS; Horton LG; Beamer WG; Rosen CJ
Prostate; 2006 Jun; 66(8):789-800. PubMed ID: 16482567
[TBL] [Abstract][Full Text] [Related]
23. Tumor-bone interactions in skeletal metastasis.
Orr FW; Sanchez-Sweatman OH; Kostenuik P; Singh G
Clin Orthop Relat Res; 1995 Mar; (312):19-33. PubMed ID: 7634602
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention.
Lipton A
J Support Oncol; 2004; 2(3):205-13; discussion 213-4, 216-7, 219-20. PubMed ID: 15328823
[TBL] [Abstract][Full Text] [Related]
25. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
Dai J; Keller J; Zhang J; Lu Y; Yao Z; Keller ET
Cancer Res; 2005 Sep; 65(18):8274-85. PubMed ID: 16166304
[TBL] [Abstract][Full Text] [Related]
26. Transient exposure to PTHrP (107-139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro.
de Gortázar AR; Alonso V; Alvarez-Arroyo MV; Esbrit P
Calcif Tissue Int; 2006 Nov; 79(5):360-9. PubMed ID: 17120184
[TBL] [Abstract][Full Text] [Related]
27. Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.
Nadiminty N; Lou W; Lee SO; Mehraein-Ghomi F; Kirk JS; Conroy JM; Zhang H; Gao AC
Clin Cancer Res; 2006 Mar; 12(5):1420-30. PubMed ID: 16533764
[TBL] [Abstract][Full Text] [Related]
28. Bone-related growth factors and zoledronic acid regulate the PTHrP/PTH.1 receptor bioregulation systems in MG-63 human osteosarcoma cells.
Tenta R; Sourla A; Lembessis P; Koutsilieris M
Anticancer Res; 2006; 26(1A):283-91. PubMed ID: 16475708
[TBL] [Abstract][Full Text] [Related]
29. The critical role of the bone microenvironment in cancer metastases.
Casimiro S; Guise TA; Chirgwin J
Mol Cell Endocrinol; 2009 Oct; 310(1-2):71-81. PubMed ID: 19616059
[TBL] [Abstract][Full Text] [Related]
30. Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.
Fisher JL; Thomas-Mudge RJ; Elliott J; Hards DK; Sims NA; Slavin J; Martin TJ; Gillespie MT
Cancer Res; 2006 Apr; 66(7):3620-8. PubMed ID: 16585187
[TBL] [Abstract][Full Text] [Related]
31. [Bone-related events in breast cancer].
Kurebayashi J
Clin Calcium; 2008 Apr; 18(4):447-54. PubMed ID: 18379025
[TBL] [Abstract][Full Text] [Related]
32. Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.
Wakchoure S; Swain TM; Hentunen TA; Bauskin AR; Brown DA; Breit SN; Vuopala KS; Harris KW; Selander KS
Prostate; 2009 May; 69(6):652-61. PubMed ID: 19152406
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy.
Kozlow W; Guise TA
J Mammary Gland Biol Neoplasia; 2005 Apr; 10(2):169-80. PubMed ID: 16025223
[TBL] [Abstract][Full Text] [Related]
34. [Mechanism and strategy for treatment of cancer metastasis to bone].
Yoneda T
Gan To Kagaku Ryoho; 2011 Jun; 38(6):877-84. PubMed ID: 21677475
[TBL] [Abstract][Full Text] [Related]
35. New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft.
LeRoy BE; Thudi NK; Nadella MV; Toribio RE; Tannehill-Gregg SH; van Bokhoven A; Davis D; Corn S; Rosol TJ
Prostate; 2006 Aug; 66(11):1213-22. PubMed ID: 16683269
[TBL] [Abstract][Full Text] [Related]
36. Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP).
Liao J; McCauley LK
Cancer Metastasis Rev; 2006 Dec; 25(4):559-71. PubMed ID: 17165129
[TBL] [Abstract][Full Text] [Related]
37. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
[TBL] [Abstract][Full Text] [Related]
38. Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.
Goya M; Ishii G; Miyamoto S; Hasebe T; Nagai K; Yonou H; Hatano T; Ogawa Y; Ochiai A
Prostate; 2006 Nov; 66(15):1573-84. PubMed ID: 16927388
[TBL] [Abstract][Full Text] [Related]
39. [Physiopathology of tumor-induced osteolysis].
Gouin F; Moreau A; Guicheux J; Passuti N; Heymann D
Rev Chir Orthop Reparatrice Appar Mot; 1999 Mar; 85(1):58-68. PubMed ID: 10327468
[TBL] [Abstract][Full Text] [Related]
40. Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer.
Halvorson KG; Sevcik MA; Ghilardi JR; Rosol TJ; Mantyh PW
Clin J Pain; 2006 Sep; 22(7):587-600. PubMed ID: 16926574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
